{"product_id":"global-epidemiology-of-cancer-9781119817444","title":"Global Epidemiology of Cancer","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eGLOBAL EPIDEMIOLOGY OF CANCER\u003c\/b\u003e  \u003cp\u003eCancer is the second highest cause of death in the United States, and a leading cause of death globally. Our goals are to discuss the global epidemiology of various cancers, with detailed information on their prevalence, incidence, and clinical considerations. Epidemiology is the key to understanding the mortality and morbidity of cancer, and how we can prevent, diagnose, and treat the disease. Prevention of cancer is essential for saving lives. Prevalence and incidence of cancer are key factors that each government and population must be aware of. Advances in the study of cancer occur on a regular basis, and this book provides the latest insights about relationships between the disease and stem cells, tumorigenesis, molecular interactions, pathways, channels, and immunity. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eGlobal Epidemiology of Cancer: Diagnosis and Treatment \u003c\/i\u003emeets the needs of readers by providing current information about epidemiology (including molecular epidemiol\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003eAbout the Authors xv\u003c\/p\u003e \u003cp\u003ePreface xvii\u003c\/p\u003e \u003cp\u003eAcknowledgments xix\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I Introduction \u003c\/b\u003e\u003cb\u003e1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Pathogenesis of Cancer \u003c\/b\u003e\u003cb\u003e3\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe Origin of Cancer 3\u003c\/p\u003e \u003cp\u003eCancer Biology 7\u003c\/p\u003e \u003cp\u003eGenetics and Cancer 9\u003c\/p\u003e \u003cp\u003eCell Division 11\u003c\/p\u003e \u003cp\u003eCell Cycle 12\u003c\/p\u003e \u003cp\u003eCarcinogenesis 14\u003c\/p\u003e \u003cp\u003eMutation and Cancer 16\u003c\/p\u003e \u003cp\u003eMetastasis 17\u003c\/p\u003e \u003cp\u003eKey Terms 20\u003c\/p\u003e \u003cp\u003eBibliography 20\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Global Epidemiology of Cancer \u003c\/b\u003e\u003cb\u003e23\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIncidence 23\u003c\/p\u003e \u003cp\u003ePrevalence 24\u003c\/p\u003e \u003cp\u003eSurvival 26\u003c\/p\u003e \u003cp\u003eDistribution of Cancer by Gender, Race, and Age 28\u003c\/p\u003e \u003cp\u003eGlobal Burden of Cancer 29\u003c\/p\u003e \u003cp\u003eGlobal Trends in Cancer 31\u003c\/p\u003e \u003cp\u003eGlobal Prevalence of Cancer 32\u003c\/p\u003e \u003cp\u003eGlobal Incidence and Mortality 32\u003c\/p\u003e \u003cp\u003eMortality due to Cancer in the United States 33\u003c\/p\u003e \u003cp\u003eRisk Factors for Cancer Development 34\u003c\/p\u003e \u003cp\u003eYears of Life Lost 36\u003c\/p\u003e \u003cp\u003eDisability-Adjusted Life Years 36\u003c\/p\u003e \u003cp\u003eGlobal Cancer Prevention 36\u003c\/p\u003e \u003cp\u003eKey Terms 38\u003c\/p\u003e \u003cp\u003eBibliography 38\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Cancers of the Body Systems \u003c\/b\u003e\u003cb\u003e41\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Brain and Spine Tumors \u003c\/b\u003e\u003cb\u003e43\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBenign \/ Low Grade Tumors 43\u003c\/p\u003e \u003cp\u003eMeningioma 44\u003c\/p\u003e \u003cp\u003eHemangioma 48\u003c\/p\u003e \u003cp\u003eNeurofibroma 51\u003c\/p\u003e \u003cp\u003eSchwannoma 53\u003c\/p\u003e \u003cp\u003eAstrocytoma 55\u003c\/p\u003e \u003cp\u003ePituitary Adenoma 59\u003c\/p\u003e \u003cp\u003eMalignant Tumors 62\u003c\/p\u003e \u003cp\u003ePituitary Carcinoma 63\u003c\/p\u003e \u003cp\u003ePineoblastoma 65\u003c\/p\u003e \u003cp\u003eAnaplastic Oligodendroglioma 67\u003c\/p\u003e \u003cp\u003eAnaplastic Ependymoma 69\u003c\/p\u003e \u003cp\u003eAnaplastic Astrocytoma 70\u003c\/p\u003e \u003cp\u003eEmbryonal Carcinoma 73\u003c\/p\u003e \u003cp\u003eChoriocarcinoma 74\u003c\/p\u003e \u003cp\u003eTeratoma 75\u003c\/p\u003e \u003cp\u003eMetastatic Tumors 77\u003c\/p\u003e \u003cp\u003eKey Terms 80\u003c\/p\u003e \u003cp\u003eBibliography 81\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Endocrine Tumors \u003c\/b\u003e\u003cb\u003e85\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThyroid Adenoma 85\u003c\/p\u003e \u003cp\u003eThyroid Cancers 87\u003c\/p\u003e \u003cp\u003ePapillary Carcinoma 87\u003c\/p\u003e \u003cp\u003eFollicular Carcinoma 91\u003c\/p\u003e \u003cp\u003eMedullary Carcinoma 93\u003c\/p\u003e \u003cp\u003eAnaplastic Thyroid Carcinoma 96\u003c\/p\u003e \u003cp\u003eParathyroid Tumors 98\u003c\/p\u003e \u003cp\u003eAdenoma 98\u003c\/p\u003e \u003cp\u003eCarcinoma 100\u003c\/p\u003e \u003cp\u003eThymus Tumors 102\u003c\/p\u003e \u003cp\u003eThymoma 102\u003c\/p\u003e \u003cp\u003eThymolipoma 105\u003c\/p\u003e \u003cp\u003eThymoliposarcoma 106\u003c\/p\u003e \u003cp\u003eAdrenal Tumors 108\u003c\/p\u003e \u003cp\u003eAdenoma of the Cortex 108\u003c\/p\u003e \u003cp\u003eCarcinoma of the Cortex 110\u003c\/p\u003e \u003cp\u003ePheochromocytoma 114\u003c\/p\u003e \u003cp\u003eNeuroblastoma 116\u003c\/p\u003e \u003cp\u003eMultiple Endocrine Neoplasia 119\u003c\/p\u003e \u003cp\u003eKey Terms 124\u003c\/p\u003e \u003cp\u003eBibliography 124\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Respiratory Tumors \u003c\/b\u003e\u003cb\u003e127\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eNasopharyngeal Tumors 127\u003c\/p\u003e \u003cp\u003eNasopharyngeal Angiofibroma 127\u003c\/p\u003e \u003cp\u003eNasopharyngeal Hemangioma 128\u003c\/p\u003e \u003cp\u003eNasopharyngeal Carcinoma 128\u003c\/p\u003e \u003cp\u003eLaryngeal Cancer 131\u003c\/p\u003e \u003cp\u003eLung Cancer 135\u003c\/p\u003e \u003cp\u003eBronchial Carcinoma 148\u003c\/p\u003e \u003cp\u003eCarcinoid Tumors 151\u003c\/p\u003e \u003cp\u003eMesothelioma 155\u003c\/p\u003e \u003cp\u003eKey Terms 161\u003c\/p\u003e \u003cp\u003eBibliography 161\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Digestive Tumors \u003c\/b\u003e\u003cb\u003e165\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eOral and Oropharyngeal Cancer 165\u003c\/p\u003e \u003cp\u003eEsophageal Cancer 171\u003c\/p\u003e \u003cp\u003eStomach Cancer 176\u003c\/p\u003e \u003cp\u003eSmall-Bowel Tumors 180\u003c\/p\u003e \u003cp\u003eFamilial Adenomatous Polyposis 183\u003c\/p\u003e \u003cp\u003eColorectal Tumors 186\u003c\/p\u003e \u003cp\u003eAnorectal Cancer 191\u003c\/p\u003e \u003cp\u003ePancreatic Cancer 194\u003c\/p\u003e \u003cp\u003eLiver and Biliary Tract Cancers 198\u003c\/p\u003e \u003cp\u003eHepatocellular Carcinoma 198\u003c\/p\u003e \u003cp\u003eLiver Metastases 201\u003c\/p\u003e \u003cp\u003eGallbladder Cancer 204\u003c\/p\u003e \u003cp\u003eKey Terms 208\u003c\/p\u003e \u003cp\u003eBibliography 208\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Lymphatic and Blood Cancer \u003c\/b\u003e\u003cb\u003e211\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eLymphomas 211\u003c\/p\u003e \u003cp\u003eNon-Hodgkin’s Lymphoma 211\u003c\/p\u003e \u003cp\u003eHodgkin’s Lymphoma 216\u003c\/p\u003e \u003cp\u003eMultiple Myeloma 222\u003c\/p\u003e \u003cp\u003eLeukemias 225\u003c\/p\u003e \u003cp\u003eAcute Lymphoblastic Leukemia 226\u003c\/p\u003e \u003cp\u003eAcute Myeloid Leukemia 230\u003c\/p\u003e \u003cp\u003eChronic Lymphocytic Leukemia 234\u003c\/p\u003e \u003cp\u003eChronic Myeloid Leukemia 237\u003c\/p\u003e \u003cp\u003eKey Terms 239\u003c\/p\u003e \u003cp\u003eBibliography 240\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Male Reproductive Tumors \u003c\/b\u003e\u003cb\u003e243\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBenign Prostatic Hyperplasia 243\u003c\/p\u003e \u003cp\u003eProstate Cancer 248\u003c\/p\u003e \u003cp\u003eTesticular Cancer 256\u003c\/p\u003e \u003cp\u003ePenile Cancer 261\u003c\/p\u003e \u003cp\u003eKey Terms 264\u003c\/p\u003e \u003cp\u003eBibliography 265\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Female Reproductive Tumors \u003c\/b\u003e\u003cb\u003e269\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBenign Breast Tumors 269\u003c\/p\u003e \u003cp\u003eBreast Cancer 272\u003c\/p\u003e \u003cp\u003eBenign Ovarian Masses 286\u003c\/p\u003e \u003cp\u003eOvarian Cancer 290\u003c\/p\u003e \u003cp\u003eUterine Fibroids 296\u003c\/p\u003e \u003cp\u003eEndometrial Cancer 300\u003c\/p\u003e \u003cp\u003eUterine Sarcoma 306\u003c\/p\u003e \u003cp\u003eChoriocarcinoma 309\u003c\/p\u003e \u003cp\u003eCervical Polyps 311\u003c\/p\u003e \u003cp\u003eCervical Cancer 312\u003c\/p\u003e \u003cp\u003eVaginal and Vulvar Cancer 318\u003c\/p\u003e \u003cp\u003eKey Terms 321\u003c\/p\u003e \u003cp\u003eBibliography 322\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Skin Tumors \u003c\/b\u003e\u003cb\u003e327\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMoles 327\u003c\/p\u003e \u003cp\u003eDermatofibromas 331\u003c\/p\u003e \u003cp\u003eInfantile Hemangiomas 332\u003c\/p\u003e \u003cp\u003eLipoma and Liposarcoma 335\u003c\/p\u003e \u003cp\u003eKeloids 337\u003c\/p\u003e \u003cp\u003eMelanoma 338\u003c\/p\u003e \u003cp\u003eBasal Cell Carcinoma 343\u003c\/p\u003e \u003cp\u003eSquamous Cell Carcinoma 347\u003c\/p\u003e \u003cp\u003eBowen Disease 350\u003c\/p\u003e \u003cp\u003eMerkel Cell Skin Cancer 353\u003c\/p\u003e \u003cp\u003eKaposi Sarcoma 355\u003c\/p\u003e \u003cp\u003eKey Terms 359\u003c\/p\u003e \u003cp\u003eBibliography 359\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Bone Tumors \u003c\/b\u003e\u003cb\u003e363\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBenign Bone Tumors 363\u003c\/p\u003e \u003cp\u003eMultiple Myeloma 368\u003c\/p\u003e \u003cp\u003eOsteosarcoma 368\u003c\/p\u003e \u003cp\u003eChondrosarcoma 373\u003c\/p\u003e \u003cp\u003eEwing Sarcoma 376\u003c\/p\u003e \u003cp\u003eGiant Cell Tumor of Bone 379\u003c\/p\u003e \u003cp\u003eMetastatic Bone Tumors 383\u003c\/p\u003e \u003cp\u003eKey Terms 386\u003c\/p\u003e \u003cp\u003eBibliography 386\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Kidney and Urinary Bladder Tumors \u003c\/b\u003e\u003cb\u003e391\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eAdenoma 391\u003c\/p\u003e \u003cp\u003eAngiomyolipoma 393\u003c\/p\u003e \u003cp\u003eRenal Cell Carcinoma 395\u003c\/p\u003e \u003cp\u003eRenal Sarcoma 400\u003c\/p\u003e \u003cp\u003eWilms’ Tumor 402\u003c\/p\u003e \u003cp\u003eMetastatic Tumors 406\u003c\/p\u003e \u003cp\u003eUrinary Bladder Cancer 408\u003c\/p\u003e \u003cp\u003eTransitional Cell Carcinoma 408\u003c\/p\u003e \u003cp\u003eSquamous Cell Carcinoma 411\u003c\/p\u003e \u003cp\u003eAdenocarcinoma 413\u003c\/p\u003e \u003cp\u003eKey Terms 415\u003c\/p\u003e \u003cp\u003eBibliography 415\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Diagnostic Procedures \u003c\/b\u003e\u003cb\u003e421\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eTraditional X-rays 421\u003c\/p\u003e \u003cp\u003eComputed Tomography 424\u003c\/p\u003e \u003cp\u003ePositron Emission Tomography 428\u003c\/p\u003e \u003cp\u003eMagnetic Resonance Imaging 431\u003c\/p\u003e \u003cp\u003eDoppler and Duplex Doppler Ultrasonography 434\u003c\/p\u003e \u003cp\u003eTransrectal Ultrasonography 436\u003c\/p\u003e \u003cp\u003eMammography 436\u003c\/p\u003e \u003cp\u003eNuclear Medicine 439\u003c\/p\u003e \u003cp\u003eEndoscopy 441\u003c\/p\u003e \u003cp\u003eEndoscopic Retrograde Cholangiopancreatography 444\u003c\/p\u003e \u003cp\u003eBiopsy 444\u003c\/p\u003e \u003cp\u003eLumbar Puncture 445\u003c\/p\u003e \u003cp\u003eHematology Tests 447\u003c\/p\u003e \u003cp\u003eUrinalysis 448\u003c\/p\u003e \u003cp\u003eGenetic Testing 450\u003c\/p\u003e \u003cp\u003eKey Terms 451\u003c\/p\u003e \u003cp\u003eBibliography 452\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Treatment of Cancers \u003c\/b\u003e\u003cb\u003e455\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Surgical Oncology \u003c\/b\u003e\u003cb\u003e457\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBiopsy Techniques 457\u003c\/p\u003e \u003cp\u003eFine-Needle Aspiration 457\u003c\/p\u003e \u003cp\u003eCore-Needle Biopsy 459\u003c\/p\u003e \u003cp\u003eOpen Biopsy 461\u003c\/p\u003e \u003cp\u003eEndoscopic Biopsies 462\u003c\/p\u003e \u003cp\u003eCardiopulmonary Factors 462\u003c\/p\u003e \u003cp\u003eHematologic Factors 463\u003c\/p\u003e \u003cp\u003eGastrointestinal Factors 464\u003c\/p\u003e \u003cp\u003eGeriatric Factors 464\u003c\/p\u003e \u003cp\u003eMedications Affecting Surgery 467\u003c\/p\u003e \u003cp\u003eAnesthesia 468\u003c\/p\u003e \u003cp\u003eResection 469\u003c\/p\u003e \u003cp\u003eTumor Margins 469\u003c\/p\u003e \u003cp\u003eSentinel Lymph Node Biopsy 470\u003c\/p\u003e \u003cp\u003eMinimally Invasive Procedures 470\u003c\/p\u003e \u003cp\u003eEmergent Surgery 472\u003c\/p\u003e \u003cp\u003eKey Terms 472\u003c\/p\u003e \u003cp\u003eBibliography 473\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Radiation Therapy \u003c\/b\u003e\u003cb\u003e475\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eThe Purpose of Radiation Therapy 476\u003c\/p\u003e \u003cp\u003eRadiobiology 476\u003c\/p\u003e \u003cp\u003eCellular Response to Radiation 476\u003c\/p\u003e \u003cp\u003eThe Cell Cycle and Radiosensitivity 477\u003c\/p\u003e \u003cp\u003eCell Death 478\u003c\/p\u003e \u003cp\u003eFactors Affecting the Biology of Cancers 479\u003c\/p\u003e \u003cp\u003eOxygen Effect 479\u003c\/p\u003e \u003cp\u003eDose Rate 480\u003c\/p\u003e \u003cp\u003eRelative Biologic Effectiveness 480\u003c\/p\u003e \u003cp\u003eRadiosensitivity 480\u003c\/p\u003e \u003cp\u003eApoptosis 480\u003c\/p\u003e \u003cp\u003eLinear Energy Transfer 481\u003c\/p\u003e \u003cp\u003eFractionation 481\u003c\/p\u003e \u003cp\u003eTypes of Radiation Therapy 483\u003c\/p\u003e \u003cp\u003eExternal Beam Radiation Therapy 483\u003c\/p\u003e \u003cp\u003eStereotactic Radiosurgery 485\u003c\/p\u003e \u003cp\u003eAdaptive Planning 486\u003c\/p\u003e \u003cp\u003eCharged Particle External Beam Radiation Therapy 487\u003c\/p\u003e \u003cp\u003eHeavy Charged Particle External Beam Radiation Therapy 487\u003c\/p\u003e \u003cp\u003eBrachytherapy 487\u003c\/p\u003e \u003cp\u003eRadionuclide Therapy 489\u003c\/p\u003e \u003cp\u003eIntraoperative Radiotherapy 489\u003c\/p\u003e \u003cp\u003eCombined-Modality Therapy 489\u003c\/p\u003e \u003cp\u003eHyperthermia 490\u003c\/p\u003e \u003cp\u003eAccidental Radiation Exposure 492\u003c\/p\u003e \u003cp\u003eAcute Radiation Syndrome 493\u003c\/p\u003e \u003cp\u003eCutaneous Syndrome 493\u003c\/p\u003e \u003cp\u003eGastrointestinal Syndrome 493\u003c\/p\u003e \u003cp\u003eHematopoietic Syndrome 493\u003c\/p\u003e \u003cp\u003eCerebrovascular Syndrome 493\u003c\/p\u003e \u003cp\u003eRadiation on the Embryo and Fetus 494\u003c\/p\u003e \u003cp\u003eRadiation and Malignancies 494\u003c\/p\u003e \u003cp\u003eSpecial Populations 495\u003c\/p\u003e \u003cp\u003ePregnant Women 495\u003c\/p\u003e \u003cp\u003eChildren 495\u003c\/p\u003e \u003cp\u003eElderly 495\u003c\/p\u003e \u003cp\u003eKey Terms 495\u003c\/p\u003e \u003cp\u003eBibliography 495\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Chemotherapy \u003c\/b\u003e\u003cb\u003e499\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003ePharmacology of Chemotherapeutic Drugs 500\u003c\/p\u003e \u003cp\u003ePrinciples of Pharmacokinetics 500\u003c\/p\u003e \u003cp\u003ePharmacogenomics 502\u003c\/p\u003e \u003cp\u003eDrug Interactions with Chemotherapy 503\u003c\/p\u003e \u003cp\u003eAntineoplastic Drugs 503\u003c\/p\u003e \u003cp\u003eClassic Alkylating Agents 505\u003c\/p\u003e \u003cp\u003ePlatinum Analogs 507\u003c\/p\u003e \u003cp\u003eMiscellaneous Alkylating Agents 508\u003c\/p\u003e \u003cp\u003eAnthracycline Antibiotics 508\u003c\/p\u003e \u003cp\u003eMiscellaneous Antitumor Antibiotics 510\u003c\/p\u003e \u003cp\u003eFolate Antagonists 510\u003c\/p\u003e \u003cp\u003ePurine Analogs 512\u003c\/p\u003e \u003cp\u003ePyrimidine Analogs 513\u003c\/p\u003e \u003cp\u003eVinca Alkaloids 514\u003c\/p\u003e \u003cp\u003eTaxanes 515\u003c\/p\u003e \u003cp\u003eHormonal Therapies 517\u003c\/p\u003e \u003cp\u003eChemotherapy-Induced Adverse Effects 520\u003c\/p\u003e \u003cp\u003eBone Marrow Suppression 520\u003c\/p\u003e \u003cp\u003eAnemia 520\u003c\/p\u003e \u003cp\u003eInsomnia 521\u003c\/p\u003e \u003cp\u003eCognitive Dysfunction 522\u003c\/p\u003e \u003cp\u003eFatigue 522\u003c\/p\u003e \u003cp\u003eThrombocytopenia 522\u003c\/p\u003e \u003cp\u003eNeutropenia 523\u003c\/p\u003e \u003cp\u003eTumor Lysis Syndrome 525\u003c\/p\u003e \u003cp\u003eGastrointestinal Tract Toxicity 526\u003c\/p\u003e \u003cp\u003eIntegumentary Toxicity 528\u003c\/p\u003e \u003cp\u003eCardiotoxicity 529\u003c\/p\u003e \u003cp\u003eNeurotoxicity 531\u003c\/p\u003e \u003cp\u003ePulmonary Toxicity 536\u003c\/p\u003e \u003cp\u003eNephrotoxicity 538\u003c\/p\u003e \u003cp\u003eHepatotoxicity 540\u003c\/p\u003e \u003cp\u003eKey Terms 542\u003c\/p\u003e \u003cp\u003eBibliography 542\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Immunotherapy \u003c\/b\u003e\u003cb\u003e545\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eImmunology Overview 545\u003c\/p\u003e \u003cp\u003eInnate Immunity 545\u003c\/p\u003e \u003cp\u003eAdaptive Immunity 546\u003c\/p\u003e \u003cp\u003eCytokines 546\u003c\/p\u003e \u003cp\u003eAntigen Presentation Cell 546\u003c\/p\u003e \u003cp\u003eTumor Escape Mechanisms 547\u003c\/p\u003e \u003cp\u003eInterleukin-2 548\u003c\/p\u003e \u003cp\u003eBiological Activity 548\u003c\/p\u003e \u003cp\u003eIndications of Interleukin-2 549\u003c\/p\u003e \u003cp\u003eInterferons 550\u003c\/p\u003e \u003cp\u003eBacillus Calmette-Guérin 551\u003c\/p\u003e \u003cp\u003eCancer Vaccines 551\u003c\/p\u003e \u003cp\u003eMajor Histocompatibility Complex 552\u003c\/p\u003e \u003cp\u003eImmunoadjuvants 553\u003c\/p\u003e \u003cp\u003eHuman Papillomavirus 553\u003c\/p\u003e \u003cp\u003eProstate Cancer 554\u003c\/p\u003e \u003cp\u003eClinical Studies of New Vaccines 554\u003c\/p\u003e \u003cp\u003eKey Terms 556\u003c\/p\u003e \u003cp\u003eBibliography 556\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Gene Therapy \u003c\/b\u003e\u003cb\u003e559\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGene Therapy Regulation 559\u003c\/p\u003e \u003cp\u003eCancer Gene Therapy 560\u003c\/p\u003e \u003cp\u003eCancer Gene Therapy Protocols 560\u003c\/p\u003e \u003cp\u003eTumor-Directed Gene Therapy Protocols 560\u003c\/p\u003e \u003cp\u003eSuicide Gene Therapy 560\u003c\/p\u003e \u003cp\u003eTumor-Suppressor Gene Therapy 561\u003c\/p\u003e \u003cp\u003eAntisense Oligonucleotides 561\u003c\/p\u003e \u003cp\u003eOncolytic Viral Gene Therapy 562\u003c\/p\u003e \u003cp\u003eActive Immunotherapy 562\u003c\/p\u003e \u003cp\u003eTumor-Infiltrating Lymphocytes 562\u003c\/p\u003e \u003cp\u003eCytokine Genes 563\u003c\/p\u003e \u003cp\u003eDNA Vaccines 563\u003c\/p\u003e \u003cp\u003eAdoptive Immunotherapy 563\u003c\/p\u003e \u003cp\u003eChimeric Receptors 564\u003c\/p\u003e \u003cp\u003eTumor-Specific T Cells 565\u003c\/p\u003e \u003cp\u003ePharmacogenetics and Pharmacogenomics 565\u003c\/p\u003e \u003cp\u003eEthical, Social and Legal Issues 566\u003c\/p\u003e \u003cp\u003eKey Terms 569\u003c\/p\u003e \u003cp\u003eBibliography 569\u003c\/p\u003e \u003cp\u003eGlossary 571\u003c\/p\u003e \u003cp\u003eIndex 593\u003c\/p\u003e","brand":"John Wiley \u0026 Sons Inc","offers":[{"title":"Default Title","offer_id":49407161499991,"sku":"9781119817444","price":102.55,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119817444.jpg?v=1730498387","url":"https:\/\/bookcurl.com\/products\/global-epidemiology-of-cancer-9781119817444","provider":"Book Curl","version":"1.0","type":"link"}